1
EPISODE · Mar 17, 2026 · 12 MIN
FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s
from 1nessAgency Insights
If your healthcare organization has ramped up telehealth services or digital marketing in the GLP-1 weight loss space, the FDA just drew a bright red line you cannot cross. On March 3, 2026, the agency issued 30 warning letters to telehealth companies for false or misleading claims about compounded
Embed this episode
NOW PLAYING
FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s
0:00
12:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 1nessAgency Insights?
This episode is 12 minutes long.
When was this 1nessAgency Insights episode published?
This episode was published on March 17, 2026.
Can I download this 1nessAgency Insights episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!